Welcome to LookChem.com Sign In|Join Free

Hubei Vanz Pharm Co.,Ltd

Diamond Supplier Enterprise Certification

Diamond
Supplier
6th
years
Home>>Products>>Top quality 99% Regorafenib Monohydrate powder

Product Certification&
Enterprise Certification

More Detail

Hubei Vanz Pharm Co.,Ltd

Country: China (Mainland)

Business Type:Trading Company

Ms.Chelsea gao

Tel: 86-27-84492310

Ms.Bella Li

Tel: 008618986076206

Ms.Chelsea Gao

Tel: +86 27 84492310

Ms.Wendy

Tel: WhatsApp +8615927784577

Ms.Mirriam

Tel: +8618071739296

Mobile: +8615207100586

Tel: 86-27-84492310

Fax: 86-27-84402310

URL: http://www.vanzpharm.com/en/index.html

Province/state: Hubei

City: JIAYU

Street: FANHU INDUSTRY PARK

MaxCard:


    x
  • Ms.Bella Li
  • Ms.Chelsea Gao
Contact Suppliers

Top quality 99% Regorafenib Monohydrate powder

CAS NO.1019206-88-2

  • msdsMSDS/COA Download

  • FOB Price: USD: 200.00-200.00 /Gram Get Latest Price
  • Min.Order: 100 Gram
  • Payment Terms: L/C,T/T,Other
  • Available Specifications:

    A (1-10)Gram

Contact Supplier

Product Details

Keywords

  • Regorafenib Monohydrate
  • Regorafenib Monohydrate bulk price
  • Regorafenib Monohydrate powder

Quick Details

  • ProName: Top quality 99% Regorafenib Monohydra...
  • CasNo: 1019206-88-2
  • Molecular Formula: C9H17NO2
  • Appearance: powder
  • Application: API
  • DeliveryTime: 1-3days
  • PackAge: drums /Al foil bag
  • Port: Shenzhen
  • ProductionCapacity: 1000 Metric Ton/Month
  • Purity: 99%
  • Storage: cool dry place
  • Transportation: by sea/by air/by express
  • LimitNum: 100 Gram
  • Related Substances: <0.001
  • Residue on Ignition: 0.04%
  • Heavy Metal: <10ppm
  • Valid Period: 2year
  • color: white

Superiority

Product Quick Information :

 

Product Name: 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide hydrate
CAS: 1019206-88-2
MF: C21H17ClF4N4O4
MW: 500.83
EINECS: 1308068-626-2

 

 

What is Regorafenib

Regorafenib (BAY 73-4506, commercial name Stivarga) is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. Since 2009 it was studied as a potential treatment option in multiple tumor types.[1] By 2015 it had 2 US approvals for advanced cancers.

 

 

 

 

 

 

Details

COMPANY INFORMATION :

Hubei Vanzpharm co.,ltd , which is specialized in custom synthesis and R&D, is located in Wuhan, China.  We have established long-term cooperation with Shanghai Institute of Organic Chemistry, WuhanUniversity etc. As a special team in organic chemistry and medicinal chemistry, we support the technology of R&D on new product.We have strong advantages on the process research and product R&D, pay attention to researching and developing new technologywhich is self-owned intellectual property right. We are special at developing Drug for the respiratory, antidepressant, antivirus.We have completed R&D of more than 20 APIs and intermediates after the company founded.

R&D
Our R&D center covers an area of 1000 square meters, with four synthesis labs, one scale-up pilot labs and one analytical lab. Thelab is equipped with complete laboratory facilities and equipment. We have a professional research team of highly qualified andexperienced chemists. most of our R&D team are Master and higher. With their effort, we quickly transfer the science fruit intoproduction. Our manufacturing site is located in Wuhan which is equipped with 100L~5000L reactors; we can offer one-stop services from R&D to commercial production. (Normal reaction/ High-pressure reaction/ Catalytic reaction/ Low-Temperature reaction).

 

 

PACKING & SHIPMENT ::

25KG/Drum ;Al foil bag for small pacakge 

COMPANY CERTIFICATE :